FOLD
Knobias Clip Report (10-23-2007)
Wednesday, October 24th, 2007Rating 3.00 out of 5
[?]Submitted By Knobias ClipReport
FOLD: Sees 52-Week High on Tuesday After Positive Ph I Study for Pompe Disease
Shares of Amicus Therapeutics, Inc. (FOLD) hit a 52-week high on Tuesday after it announced positive results from two completed Phase 1 clinical studies of AT2220 (1-deoxynojirimycin HCl) for Pompe disease. The Phase 1 results […]
